Please assess the completion status of the following clinical trial:

Trial Title: Technology Delivered Diabetes-Modified Behavioral Activation Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥21 years~* Clinical diagnosis of T2DM and HbA1c ≥8% at the screening visit;~* Self-identified as AA~* Subject must be willing to use the FORA monitoring system for 6 months~* Subject must be willing to use the study assigned smartphone including videoconferencing, lifestyle monitoring and medication monitoring apps for 6 months~* Subjects must be able to communicate in English~* Subjects must have access to a landline or Ethernet for FORA data uploads for the study period.~Exclusion Criteria:~* Mental confusion on interview suggesting significant dementia~* Participation in other diabetes clinical trials~* Alcohol or drug abuse/dependency~* Active psychosis or acute mental disorder~* Life expectancy \<6 months.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Group 1 (Type: OTHER): Arm: Other: Group 1 Participants in this group will receive the culturally tailored education booklet titled Your Guide to Sugar Diabetes. In addition, subjects will complete 10 sessions of diabetes education delivered weekly via videoconferencing lasting 60 minutes each session as detailed above.
- Group 2 (Type: ACTIVE_COMPARATOR): Arm: Active Comparator: Group 2 Participants in this group will receive as detailed above, the culturally tailored education booklet titled My Guide to Sugar Diabetes. In addition, subjects will complete 10 sessions of diabetes education delivered weekly via videoconferencing lasting 60 minutes each session. Patients will also be assigned the FORA Test-n-Go Series Blood Glucose and Blood Pressure monitors and provided glucose test strips to allow testing at least once a day during the initial face-to-face session.
- Group 3 (Type: EXPERIMENTAL): Arm: Experimental: Group 3 The intervention has 3 components: 1) diabetes education; 2) home telemonitoring; and 3) diabetes modified behavioral activation, delivered by nurses via smartphones. Trained nurses will deliver the TECH DM-BAT intervention via videoconferencing technology on smartphones.

Based on this trial design, predict the completion outcome and termination type (if applicable).